Discontinued OTC asthma med may make comeback

Share this article:

OTC inhaler Primatene Mist officially left the building in August 2013, just over two years after it was banned because the prescription-free asthma inhaler's chlorofluorocarbons violated environmental regulations.

Regulatory Focus reports that the last of the inhalers was officially off the market this summer, but that a Federal Register notice indicates the FDA's Pulmonary-Allergy Drugs Advisory Committee is set to consider an OTC replacement Feb. 25. The new Primatene Mist is currently operating under the name Primatene HFA.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions